Genalice

The companies will join their respective technologies to offer customers a single solution for next-generation sequencing data interpretation.

The company also extended its existing licensing agreement with Genalice, signed in 2013, to improve plant DNA analysis.

The companies began working together in 2012 to validate the read alignment and variant calling technology for use in plant genomics.

Besides optimizing open-source code, the company has forged focused partnerships with multiple bioinformatics firms including Edico Genome and Curoverse. 

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.